Stephen J Rodgers, MD | |
1701 Augustine Cut Off, Suite 14, Wilmington, DE 19803-4415 | |
(302) 421-9111 | |
Not Available |
Full Name | Stephen J Rodgers |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 1701 Augustine Cut Off, Wilmington, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699833475 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | C1-0003358 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephen J Rodgers, MD 1701 Augustine Cut Off, Suite 14, Wilmington, DE 19803-4415 Ph: (302) 421-9111 | Stephen J Rodgers, MD 1701 Augustine Cut Off, Suite 14, Wilmington, DE 19803-4415 Ph: (302) 421-9111 |
News Archive
USANA Health Sciences, Inc. announced today that a third-party clinical study led by Dr. David Greene at Australian Catholic University (ACU National) found that use of USANA's Active Calcium™ Chewable supplement improves bone health in young girls.
Recently, a drug named Pixantrone (PIX) was developed, which is far less damaging to the heart than previous, less advanced compounds. PIX is now used to treat cancers including non-Hodgkin's lymphoma and leukaemia, but a detailed knowledge of the molecular processes it uses to destroy cancer cells has been lacking so far.
PROLOR Biotech, Inc., today announced that it has entered into a definitive license agreement with Yeda Research and Development Company Ltd. for novel technology utilized in the development of long-acting therapeutic peptides and small molecules, termed Reversible PEGylation.
Clovis Oncology today announced results from an ongoing Phase 1/2a monotherapy study evaluating lucitanib, the Company's novel, potent inhibitor of the tyrosine kinase activity of fibroblast growth factor receptors 1 through 3 (FGFR1-3), vascular endothelial growth factor receptors 1 through 3 (VEGFR1-3) and platelet-derived growth factor receptors alpha and beta (PDGFRα-β).
› Verified 7 days ago
Dr. Raymond R Strocko, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: D-5014 Dupont Co, 1007 N. Market St., Wilmington, DE 19898 Phone: 302-774-8666 Fax: 302-773-6030 | |
Dr. Bruce Henry Mcfall, DO Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 N Bancroft Pkwy, Suite 203, Wilmington, DE 19805 Phone: 302-652-2455 Fax: 302-652-2444 | |
Miss Jennifer Irene Hall, LMT, BCBTMB Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 2417 Silverside Rd Ste 4, Wilmington, DE 19810 Phone: 302-463-6043 |